Showing all 8 results
Chlorthalidone Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Bioavailability Tablet, packed in moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the stability of the micronized active ingredient.
Active Ingredient Strength Primary Clinical Function Chlorthalidone USP/BP 6.25 mg / 12.5 mg The Contemporary Starting Dose: Highly preferred for modern “Low-Dose” hypertension therapy to maximize pressure control while minimizing electrolyte loss. Chlorthalidone USP/BP 25 mg The High-Potency Payload: Utilized for resistant hypertension or the management of edema associated with heart failure or hepatic cirrhosis. Excipients Microcrystalline Cellulose / Colloidal Silicon Dioxide / Magnesium Stearate / Pregelatinized Starch Diluent / Glidant / Lubricant / Binder (Engineered specifically utilizing Micronized API Technology to ensure absolute uniformity in the 6.25mg and 12.5mg ultra-low-dose tablets, guaranteeing consistent renal response across every batch). Dapagliflozin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Hydrolytically Shielded Microdose Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the sensitive propanediol monohydrate active ingredient.
Active Ingredient Strength Primary Clinical Function Dapagliflozin (as Propanediol Monohydrate) USP/Ph.Eur. 5 mg The Titration & Hepatic Anchor: The definitive starting dose utilized for patients with severe hepatic impairment or those at high risk for volume depletion (hypotension). Dapagliflozin (as Propanediol Monohydrate) USP/Ph.Eur. 10 mg The Cardio-Renal Macrodose: The massive, globally standardized therapeutic payload required for the aggressive, daily maintenance of Heart Failure, CKD, and Type 2 Diabetes. Excipients Microcrystalline Cellulose / Anhydrous Lactose / Crospovidone / Silicon Dioxide / Magnesium Stearate / Premium Polymeric Film Diluent / Densifier / Superdisintegrant / Glidant / Heavy Film-Coating (Engineered specifically utilizing Strict Low-Humidity Granulation to prevent the highly sensitive API from degrading during compression, sealed with an impenetrable film-coat to block environmental moisture and ensure rapid gastric dissolution) *Pack Sizes: 10×10 Alu-Alu Blisters or 14/28-Tablet Calendar Packs (Optimized specifically for strict chronic cardio-renal dispensing regimens).
Furosemide & Spironolactone Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of both active pharmaceutical ingredients.
Active Ingredient Strength Primary Clinical Function Furosemide USP/Ph.Eur. 20 mg The Loop Diuretic (Fluid Clearance): Rapidly eliminates severe fluid buildup (edema) from the lungs, abdomen, and peripheral tissues. Spironolactone USP/Ph.Eur. 50 mg The Potassium-Sparing Shield: Blocks aldosterone, prevents toxic cardiac fibrosis, and heavily protects the patient against lethal hypokalemia. Excipients Microcrystalline Cellulose / Lactose Monohydrate / Sodium Starch Glycolate / Povidone K-30 / Magnesium Stearate / Premium Polymeric Film Diluent / Binder / Superdisintegrant / Slipper-Coating (Engineered utilizing advanced wet-granulation to ensure both the rapid-acting Furosemide and the slower-acting Spironolactone dissolve at precise, synchronized rates to guarantee the electrolyte-sparing synergy) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict chronic cardiology and hepatology dispensing regimens).
Glibenclamide, Metformin & Pioglitazone Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the three highly reactive APIs.
Active Ingredient Strength Primary Clinical Function Glibenclamide USP/Ph.Eur. 5 mg The Secretagogue (Micro-Dose): Triggers rapid, potent insulin release from the pancreas to control acute post-prandial (after-meal) glucose spikes. Pioglitazone (as Hydrochloride) USP/Ph.Eur. 15 mg The Sensitizer (Micro-Dose): Reverses deep cellular insulin resistance in skeletal muscle and adipose tissue. Metformin Hydrochloride USP/Ph.Eur. 500 mg (IR or ER) The Hepatic Anchor (Macro-Dose): Provides baseline suppression of liver glucose production. Frequently formulated in a sustained-release matrix to minimize severe GI side effects. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Hypromellose / Magnesium Stearate / Premium Opadry Film Diluent / Superdisintegrant / Binder (ER Polymer) / Lubricant (Engineered utilizing elite multi-stage geometric dilution to guarantee that the lethal 5mg micro-dose of Glibenclamide is flawlessly and evenly distributed throughout the massive 500mg Metformin matrix) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for strict, chronic diabetic dispensing regimens).
Ivabradine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the highly hygroscopic hydrochloride salt.
Active Ingredient Strength Primary Clinical Function Ivabradine (as Hydrochloride) USP/Ph.Eur. 5 mg Initiation / Titration Standard: Base therapeutic unit utilized twice daily for the safe initiation of therapy, allowing the cardiologist to monitor resting heart rate before upward titration. Ivabradine (as Hydrochloride) USP/Ph.Eur. 7.5 mg Global Maintenance Standard: High-efficacy adult maintenance dose to strictly maintain the resting heart rate between 50 and 60 beats per minute. Excipients Lactose Monohydrate / Maize Starch / Maltodextrin / Colloidal Silicon Dioxide / Magnesium Stearate / Premium Opadry Film Diluent / Binder / Glidant / Lubricant / Film-Coating (Engineered specifically using precise geometric dilution to ensure the micro-dose API is flawlessly distributed, preventing accidental bradycardia from “hot spots” in a poorly blended generic tablet) *Pack Sizes: 10×10 Blisters or Bottles of 56 (Optimized specifically for strict 28-day chronic cardiology dispensing regimens).
Metoprolol & Ramipril Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered, API-Segregated Bilayer Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the highly degradable Ramipril molecule.
Active Ingredient Strength Primary Clinical Function Metoprolol (as Succinate/Tartrate) Ph.Eur./USP 25 mg / 50 mg Cardioselective Base: Reduces heart rate, cardiac output, and myocardial oxygen demand; protects against sudden cardiac death. Ramipril Ph.Eur./USP 2.5 mg / 5 mg ACE Inhibitor Driver: Forces profound systemic vasodilation, protects the kidneys (renoprotection), and halts pathological cardiac remodeling. Excipients Microcrystalline Cellulose / Sodium Stearyl Fumarate / Hypromellose / Sodium Bicarbonate / Iron Oxide Colors Low-Moisture Diluent / Lubricant / Film-Coating / Polymeric Stabilizer (Engineered specifically to physically isolate the acidic Ramipril from cross-reacting with the Metoprolol salt, preventing the formation of toxic diketopiperazine impurities) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for strict 30-day chronic cardiology dispensing regimens).
Nebivolol Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Low-Dose Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or high-density PVC/PVDC blister strips to ensure the absolute chemical stability of the hydrochloride salt.
Active Ingredient Strength Primary Clinical Function Nebivolol (as HCl) Ph.Eur./USP 2.5 mg / 5 mg Global Hypertension Standard: Base therapeutic unit for the continuous, highly tolerated management of essential hypertension. Nebivolol (as HCl) Ph.Eur./USP 10 mg / 20 mg Advanced Cardiac Standard: High-dose maintenance therapy for refractory hypertension and specialized heart failure protocols. Excipients Lactose Monohydrate / Microcrystalline Cellulose / Croscarmellose Sodium / Hypromellose / Polysorbate 80 / Magnesium Stearate Diluent / Superdisintegrant / Wetting Agent / Lubricant (Engineered specifically to ensure rapid, predictable gastric dissolution while protecting the delicate racemic balance of the API) *Pack Sizes: 10×10 Blisters or 28/30-Tablet Calendar Packs (Optimized specifically for strict, high-compliance chronic cardiology dispensing regimens).
Torsemide Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Uncoated Tablet, packed in highly secure, moisture-resistant Alu-PVC or opaque Alu-Alu blister strips, providing dosage flexibility for both mild hypertension and severe renal failure.
Active Ingredient Strength Primary Clinical Use Torsemide USP/Ph.Eur. 5 mg / 10 mg Standard maintenance therapy for mild-to-moderate congestive heart failure and essential hypertension. Torsemide USP/Ph.Eur. 20 mg Acute diuresis for severe hepatic cirrhosis and advanced heart failure exacerbations. Torsemide USP/Ph.Eur. 100 mg High-dose therapy specifically reserved for patients with severe chronic renal failure (CRF) and massive fluid overload. Excipients Lactose Monohydrate / Crospovidone / Magnesium Stearate Diluent / Superdisintegrant / Lubricant (Engineered for immediate, predictable gastric dissolution)
